AAPS
AAPS 2022
AAPS 2022 PharmSci 360
October 16-19, 2022 | Boston, MA
WuXi AppTec is proud to be exhibiting at the AAPS PharmSci 360 annual meeting in Boston, Massachusetts, October 16-29, 2022. Visit us at Booth #723 to talk to our experts in person.

Presentations
Keys to the Successful Development of Bioanalytical Method for Oligonucleotides
Date: Monday October 17, 2022
Time: 9:30 AM-10:00 AM
Speaker: Jim Yamashita, Ph.D. Senior Director for BAS, WuXi AppTec
The Bioanalysis of ADC Therapeutics in Monkey Serum by IC-LC-MS in the Lead Nomination Stage
Date: Monday October 17, 2022
Time: 3:30 PM-3:45 PM
Speaker: Jim Yamashita, Ph.D. Senior Director for BAS, WuXi AppTec
Posters
1. The Bioanalysis of ADC Therapeutics in Monkey Serum by IC-LC-MS in the Lead Nomination Stage
Presenter: Jim Yamashita, Ph.D. Senior Director for BAS, WuXi AppTec
2. Quantitative Determination of Arsenic in Dog Blood and Human Blood by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for Arsenic Drug Development in Pre-Clinical and Clinical Studies
Presenter: Changming (Charlie) Yang, Ph.D. Senior Director for Testing Division, WuXi AppTec
3. Establishment of Preclinical Immunotoxicity Reference Based on a Large-Scale Immunophenotyping Data in Cynomolgus Monkey
Presenter: Jinping Lai, Ph.D. Director for Large Molecules, WuXi AppTec
4. Tissue Distribution using Quantitative Whole Body Autoradiography (QWBA) of [14C]-Paclitaxel in Tumor Bearing Mice
Presenter: Leah Lake, M.S. Group Leader of Autoradiography, WuXi AppTec
About AAPS
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members and over 10,000 actively participating stakeholders employed in academia, industry, government, and other pharmaceutical science related research institutes worldwide. This year’s annual meeting will be held at the Boston Convention and Exhibition Center.
Attending AAPS 2022? Meet With an Expert
Plan to visit our Booth #723 or schedule a virtual meeting with one of our subject matter experts.